Inventor · Andover, MA, US

John Wang

16Patents
5h-index
80Co-inventors
65Inventor score

Filing activity: Mar 7, 2003 → Dec 20, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8329742B2 Macrocyclic compounds useful as pharmaceuticals Emerging Cross-Sectional Technologies 9 Active
US7799827B2 Macrocyclic compounds useful as pharmaceuticals Emerging Cross-Sectional Technologies 9 Expired
US7915306B2 Macrocyclic compounds useful as pharmaceuticals Chemistry; Metallurgy 8 Expired
US9434697B2 Pyrimidine FGFR4 inhibitors Chemistry; Metallurgy 5 Active
US9730931B2 Pyrimidine FGFR4 inhibitors Chemistry; Metallurgy 5 Active
US9796683B2 Tetrasubstituted alkene compounds and their use Chemistry; Metallurgy 4 Active
US9481669B2 Pladienolide pyridine compounds and methods of use Chemistry; Metallurgy 3 Active
US8937056B2 Multikinase inhibitors for use in the treatment of cancer Human Necessities 2 Active
US8609640B2 Multikinase inhibitors for use in the treatment of cancer Human Necessities 1 Active
US10537571B2 Pyrimidine FGFR4 inhibitors Chemistry; Metallurgy 0 Active
US10851065B2 Tetrasubstituted alkene compounds and their use Chemistry; Metallurgy 0 Active
US11926619B2 Certain pladienolide compounds and methods of use Chemistry; Metallurgy 0 Active
US11160783B2 Multikinase inhibitors for use in the treatment of cancer Human Necessities 0 Active
US10912774B2 Pyrimidine FGFR4 inhibitors Chemistry; Metallurgy 0 Active
US11498916B2 Crystalline FGFR4 inhibitor compound and uses thereof Chemistry; Metallurgy 0 Active
US10745387B2 Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.